Effects and Safety of Allisartan Isoproxil Combined With Amlodipine or Indapamide in Patients With Hypertension Who Failed Allisartan Monotherapy

Wang, Hong-yi
Wu, Fang
Wang, Ji-hua
Ma, Qing-chun
Yang, Fan
Lu, Xi-ning
Huo, Yong
Sun, Ning-ling

Hypertension Research Room, Peking University Peoples’ Hospital, Beijing Key Laboratory of Early Prediction and Intervention of Acute Myocardial Infarction, Beijing, China
Medical Affairs of Shenzhen Salubris Pharmaceuticals Co. Ltd, Guangdong, China
Department of Cardiology, Peking University First Hospital, Beijing, China

Correspondence: Ning-ling Sun ([email protected]).

Revised January 05, 2022

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)

American Journal of Hypertension 35(1):p 111, January 2022. | DOI: 10.1093/ajh/hpab120